Delivery Order SPE2DB20D2104-SPE2DB23FT20H
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,177.54 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, a specialty pharmaceutical product. The award is part of a larger, previously awarded Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Bromfenac Sodium 0.09% eye drops. The $10,857.52 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical and medical products to the Department of Defense and other federal agencies. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromfenac Sodium 0.09% eye drops. The $2,180.46 Firm Fixed Price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by Amerisourcebergen's parent company, Cencora, Inc., which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $2,720.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription ophthalmic medication, with a completion date of May 17, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.29, is for the delivery of Bromfenac Sodium 0.07% Eye Drops in 3 mL containers. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This federal contract award, valued at $3,749.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Bromfenac Sodium 0.09% Eye Drops, a pharmaceutical product used for the treatment of eye conditions. The contract has an ultimate completion date of March 11, 2024, and is a Firm Fixed Price contract. This award is a child contract under a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Bromfenac Sodium 0.09% eye drops. The contract, valued at $1,138.02, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops in 1.7 ML bottles, with a total ceiling value of $8,869.82. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award is for the delivery of Bromfenac Sodium 0.09% eye drops in 1.7 mL volumes. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,315.93 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of Bromfenac Sodium 0.09% eye drop medication, valued at $10,489.61. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of May 31, 2022. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT20HDelivery Order
This federal contract award, valued at $1,000.08, was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) on April 21, 2023. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription pharmaceutical product. This award does not have a set-aside designation, indicating it was issued through full and open competition. The contract has an ultimate completion date of April 24, 2023, and is structured as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for supplying the eye drops to support the DLA's healthcare programs, which primarily serve the Department of Defense and Department of Veterans Affairs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/21/23 |